Apaziquone

Chemical compound
trends
AugustSeptemberOctoberNovemberDecember20210500
alias
EOQUIN
Apaziquone
mass
288.111 dalton
chemical formula
C₁₅H₁₆N₂O₄
media
canonical SMILES
CN1C(=C(C2=C1C(=O)C=C(C2=O)N3CC3)CO)C=CCO
isomeric SMILES
CN1C(=C(C2=C1C(=O)C=C(C2=O)N3CC3)CO)/C=C/CO
Wikipedia creation date
6/9/2009
Wikipedia incoming links count
Wikipedia opening text
Apaziquone (tentative trade name EOquin) is an indolequinone that is a bioreductive prodrug and a chemical analog of the older chemotherapeutic agent mitomycin C. In hypoxic cells, such as those on the inner surface of the urinary bladder, apaziquone is converted to active metabolites by intracellular reductases. The active metabolites alkylate DNA and lead to apoptosis. This activity is preferentially expressed in neoplastic cells. After administration of apaziquone directly into the urinary bladder (intravesically), the drug and its active metabolite were not detected in plasma, and there were no systemic side effects. Apaziquone has been applied in clinical studies sponsored by Spectrum Pharmaceuticals and Allergan for the treatment of superficial (non-muscle invasive) bladder cancer. Approximately 70% of all newly diagnosed patients with bladder cancer have non-muscle invasive bladder cancer and over one million patients in the United States and Europe are affected by the disease. The U.S. Food and Drug Administration (FDA) has granted Fast Track review status to apaziquone for this indication.
Wikipedia redirect
C15H16N2O4
EOquin
Wikipedia URL
CAS Registry Number
ChEMBL ID
ChemSpider ID
DrugBank ID
InChI
InChIKey
KEGG ID
MeSH descriptor ID
PubChem CID
UNII